Plozasiran, a siRNA therapy, effectively reduces APOC3 levels to lower triglycerides in FCS patients.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing
Plozasiran, a siRNA therapy, effectively reduces APOC3 levels to lower triglycerides in FCS patients.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing